Biblio Discovery — Demo Discovery Service

5 hasil untuk "Christopher Butler"

Menampilkan 1–5 · 0,34 detik · RSS

  1. Artikel Jurnal Teks lengkap

    The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis

    Jienchi Dorward; Thokozani Khubone; Kelly R. Gate dkk.

    The Lancet HIV · 2021 · Inggris · OpenAlex Scopus

    BACKGROUND: The effect of the COVID-19 pandemic on HIV outcomes in low-income and middle-income countries is poorly described. We aimed to measure the impact of the 2020 national COVID-19 lockdown on HIV testing and treatment in KwaZulu-Natal, South Africa, where 1·7 million people are living with…

  2. Artikel Jurnal Teks lengkap

    Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

    Christopher Butler; Jienchi Dorward; Ly‐Mee Yu dkk.

    The Lancet · 2021 · Inggris · OpenAlex

    BACKGROUND: Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19, but evidence from community randomised trials is lacking. We aimed to assess the effectiveness of azithromycin to treat suspected COVID-19 among people in the…

  3. Artikel Jurnal Teks lengkap

    Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

    Christopher Butler; Richard F. Hobbs; Oghenekome A. Gbinigie dkk.

    The Lancet · 2022 · Inggris · OpenAlex

    BACKGROUND: The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We aimed to establish whether the addition of…

  4. Artikel Jurnal

    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

    Ly‐Mee Yu; Mona Bafadhel; Jienchi Dorward dkk.

    The Lancet · 2021 · Inggris · OpenAlex

    BACKGROUND: A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We aimed to establish whether inhaled budesonide reduces time to recovery and COVID-19-related hospital admissions or…